Transaction in Own Shares

RNS Number : 6383X
Lloyds Banking Group PLC
30 April 2019
 

  

 

 


30th April 2019

 

TRANSACTIONS IN OWN SECURITIES

 

 

Lloyds Banking Group plc (the "Company") announces today that it has purchased the following number of its ordinary shares, from Morgan Stanley & Co. International plc (the "Broker").

Ordinary Shares

Date of purchases:                                                                             30th April 2019

Number of ordinary shares purchased:                                              21,899,483

Highest price paid per share (pence):                                                63.75

Lowest price paid per share (pence):                                                 62.62

Volume weighted average price paid per share (pence):                   63.18

Such purchases form part of the Company's existing share buy-back programme and were effected pursuant to the instructions issued to the Broker by the Company on 28 February 2019, as announced on 1 March 2019.

The Company intends to cancel these Shares.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a full breakdown of the individual trades made by the Broker on behalf of the Company as part of the buy-back programme is set out in the Schedule to this announcement available through the link below:

 

http://www.rns-pdf.londonstockexchange.com/rns/6383X_1-2019-4-30.pdf

 

- END -

 

For further information:

 

Investor Relations

Douglas Radcliffe                                                                               +44 (0)20 7356 1571

Group Investor Relations Director

douglas.radcliffe@lloydsbanking.com

 

 

Corporate Affairs

Matt Smith                                                                                           +44 (0)20 7356 3522

Head of Media Relations

matt.smith@lloydsbanking.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSQBLFXKZFBBBK
UK 100